OK I'll stop after this but since the letter to shareholders mentioned a Leronlimab/ stroke trial, here's an article related to that.

Leronlimab Shows Early, but Promising Clinical Responses in First Two Patients Recovering from Stroke.

https://www.otcmarkets.com/stock/CYDY/news/Le...?id=277935